LexDanaLexDanabeta
Inventor

David Glass

Inventor
Cambridge, MA, US

Overview

36→
Patents
1997–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 36 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
C07KPeptides24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C12NMicroorganisms or enzymes14%
C12YEnzymes5%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C07HSugars2%
A01KAnimal husbandry1%
C07BGeneral methods of organic chemistry1%
C07DHeterocyclic compounds1%
PatentTitleYear
11,084,880Anti-BCMA chimeric antigen receptor202110,800,793Rapamycin derivatives202010,774,388Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereof202010,703,819Treatment of cancer using a CD123 chimeric antigen receptor202010,576,076Pharmaceutical combination of everolimus with dactolisib202010,568,947Treatment of cancer using a CLL-1 chimeric antigen receptor202010,357,514Treatment of cancer using anti-CD19 Chimeric Antigen Receptor201910,286,069Low, immune enhancing, dose MTOR inhibitors and uses thereof201910,287,354Regulatable chimeric antigen receptor201910,174,095Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor201910,030,063Production of therapeutic proteins in genetically modified mammalian cells201810,004,803Low, immune enhancing, dose mtor inhibitors and uses thereof20189,815,901'Treatment of cancer using a CD123 chimeric antigen receptor'20179,475,857'Methods and compositions using a Klotho-FGF23 fusion polypeptide'20169,458,209'Methods and compositions using Klotho-FGF fusion polypeptides'20169,365,651'Method for treating metabolic disorders by administration of an anti-ActRIIB antibody'20169,139,631'Methods and compositions using FGF23 variant polypeptides with reduced aggregation and cleavage'20158,932,589'Methods and compositions using Kloto-FGF23 fusion polypeptides'20158,722,621'Stabilized insulin-like growth factor polypeptides'20148,481,031'Methods and compositions using Klotho-FGF fusion polypeptides'20138,445,434'IGF-1 fusion polypeptides and therapeutic uses thereof'20138,420,088'Methods and compositions using FGF23 fusion polypeptides'20138,343,918'Stabilized insulin-like growth factor polypeptides'20138,158,581'IGF-1 fusion polypeptides and therapeutic uses thereof'20127,837,999'Method of increasing muscle mass with IGF-1 fusion polypeptides'20107,781,404'IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof'20107,632,503'Method of treating a muscle-related condition with modified IGF1 polypeptides'20097,521,211'IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof'20097,396,918'IGF-I fusion polypeptides and therapeutic uses thereof'20087,355,018'Modified IGF1 polypeptides with increased stability and potency'20087,122,648'Ion channel receptor and uses thereof'20066,852,838'Tyrosine kinase receptors and ligands'20056,413,740'Tyrosine kinase receptors and ligands'20026,143,714'Methods of using hepatocyte growth factor to promote survival, growth and differentiation of motor neurons'20005,814,478'Tyrosine kinase receptors and ligands'19985,622,862'Assay systems for trkB neurotrophin activity'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2013Patents assigned to REGENERON PHARMA (14)· patent assignee history
1998–2000Based in White Plains, NY, US· patent location history
2002–2014Based in Cortlandt Manor, NY, US· patent location history
2013–2021Patents assigned to NOVARTIS AG (22)· patent assignee history
2013–2020Patents assigned to GLASS DAVID (7)· patent assignee history
2013–2016Patents assigned to HU SHOU-IH (4)· patent assignee history
2013–2021Based in Cambridge, MA, US· patent location history
2013Based in East Hanover, NJ, US· patent location history
2015–2016Based in Cortland, NY, US· patent location history
2017–2021Patents assigned to UNIV PENNSYLVANIA (8)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NOVARTIS AG222013–2021
REGENERON PHARMA141997–2013
UNIV PENNSYLVANIA82017–2021
GLASS DAVIDself72013–2020
HU SHOU-IH42013–2016
Locations
LocationPatentsSpan
Cambridge, Massachusetts, US162013–2021
Cortlandt Manor, New York, US132002–2014
Cortland, New York, US32015–2016
White Plains, New York, US21998–2000
East Hanover, New Jersey, US12013